Results 241 to 250 of about 1,392,421 (263)

First-Year Impact of Drug Decriminalization on Mental- and Substance Use Disorder-Related Healthcare Encounters in British Columbia: An Interrupted Time Series Analysis. [PDF]

Can J Psychiatry
Mohebbian M, Schütz C, Kazanjian A, Kassam R, Puyat JH.   +4 more
europepmc   +1 more source

The Impact of US Food and Drug Administration's Advisory and Enforcement Actions on US Sales of Esco Bars Products in 2023: Synthetic Control Approach.

JMIR Public Health Surveill
Shin H, Hannings J, Cahn Z, Xu X, Toblin R, Farrelly M, King BA.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino, Roberto Carmagnani Pestana, Shanu Modi   +2 more
exaly  

Targeted drug delivery strategies for precision medicines

Nature Reviews Materials, 2021
Mandana T Manzari, Yosi Shamay, Hiroto Kiguchi   +2 more
exaly  

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

Nature Reviews Microbiology, 2022
Véronique A Dartois, Eric J Rubin
exaly  

Drug repurposing: progress, challenges and recommendations

Nature Reviews Drug Discovery, 2018
Sudeep P Pushpakom, Francesco Iorio, Patrick A Eyers   +2 more
exaly  

Polymer–drug conjugate therapeutics: advances, insights and prospects

Nature Reviews Drug Discovery, 2018
Iriny Ekladious, Yolonda L Colson, Mark Grinstaff   +2 more
exaly  

A comprehensive map of molecular drug targets

Nature Reviews Drug Discovery, 2016
Rita Santos, Oleg Ursu, Anna Gaulton
exaly  

Opportunities and challenges in phenotypic drug discovery: an industry perspective

Nature Reviews Drug Discovery, 2017
Fabien Vincent, Jonathan A Lee, Marco Prunotto   +2 more
exaly